AORTAFIT
DEAD

Serial Number

87648953

Owner

Aortica Corporation

Attorney

James Namiki

Filing Date

Oct 17, 2017

Add to watchlist:

No watchlists yet
View on USPTO

AORTAFIT Trademark

Serial Number: 87648953

AORTAFIT is a trademark filed by Aortica Corporation on October 17, 2017. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Aortica Corporation (8 trademarks)

11811 NE 1st Street, Suite 311
Bellevue, WA 98005

Entity Type: 03

Trademark Details

Filing Date

October 17, 2017

Registration Date

Not Registered

Published for Opposition

September 18, 2018

Goods & Services

Software for evaluating patient-specific data, generating case planning information, and providing patient-specific device configurations for use by surgeons in preparing for procedures involving blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; software for evaluating patient-specific data and generating patient-specific device configurations for use by manufacturers to provide patient-specific blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices

Medical assistance and analysis, namely, evaluating patient-specific data, generating case planning information, and providing patient-specific device configurations for use by surgeons in preparing for procedures involving blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; medical assistance and analysis, namely, evaluating patient- specific data and generating patient-specific device configurations for use by manufacturers to provide patient-specific blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices

Software as a service (SaaS) services featuring software for evaluating patient-specific data, generating case planning information, and providing patient-specific device configurations for use by surgeons in preparing for procedures involving blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; software as a service (SaaS) services featuring software for evaluating patient-specific data and generating patient-specific device configurations for use by manufacturers to provide patient-specific blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; providing online non-downloadable software for evaluating patient-specific data, generating case planning information, and proposing patient-specific device configurations for use by surgeons in preparing for procedures involving blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; providing temporary use of non-downloadable cloud-based software for evaluating patient-specific data, generating case planning information, and proposing patient-specific device configurations for use by surgeons in preparing for procedures involving blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; providing online non-downloadable software for evaluating patient-specific data and generating patient-specific device configurations for use by manufacturers to provide patient-specific blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; providing temporary use of non-downloadable cloud-based software for evaluating patient-specific data and generating patient-specific device configurations for use by manufacturers to provide patient-specific blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 15, 2020 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 15, 2020 ABN6
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 25, 2020 CHAN
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 25, 2020 AITU
ASSIGNED TO LIE
Feb 11, 2020 ALIE
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 28, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 22, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 22, 2020 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 24, 2019 EXRA
SOU EXTENSION 2 GRANTED
Oct 22, 2019 EX2G
SOU EXTENSION 2 FILED
Oct 22, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 22, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 11, 2019 EXRA
SOU EXTENSION 1 GRANTED
May 9, 2019 EX1G
SOU EXTENSION 1 FILED
May 9, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
May 9, 2019 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 13, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 18, 2018 NPUB
PUBLISHED FOR OPPOSITION
Sep 18, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 29, 2018 NONP
ASSIGNED TO LIE
Aug 10, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 1, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 31, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 30, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 30, 2018 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Feb 1, 2018 GPRN
PRIORITY ACTION E-MAILED
Feb 1, 2018 GPRA
PRIORITY ACTION WRITTEN
Feb 1, 2018 CPRA
ASSIGNED TO EXAMINER
Jan 25, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2017 NWOS
NEW APPLICATION ENTERED
Oct 20, 2017 NWAP